Recruiting NA Localized Lung Carcinoma

New treatment option for Localized Lung Carcinoma

Official title New York Better Breathing Study

ClinicalTrials.gov ID: NCT06869447

What this study is testing

What it's testing
This clinical trial evaluates the effects of whether breathing exercises at home can reduce symptoms and help stage I-III lung cancer survivors stay active. Over 70% of lung cancer survivors have trouble breathing, feel tired, and have lower levels of fitness.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Age ≥ 18 years of age.
  • Able to speak, read and comprehend the English language
  • Self-identify as non-Hispanic Black or White.
  • Are \< 24 months of histologically confirmed invasive, non-metastatic, lung cancer diagnosis.
  • Have received surgical treatment (primarily stage I, II and III) and have completed all cancer treatments (surgery, chemotherapy, radiation).

You likely can't join if

  • Participant has in situ (stage 0) or metastatic (stage IV) disease at study entry.
  • Has contraindications for respiratory muscle training (e.g., recent pulmonary embolism, aortic aneurysm, current pneumothorax).
  • Is actively engaging in a structured exercise program and/or meeting exercise guidelines.
  • Unwilling or unable to follow protocol requirements.
  • Any condition which in the investigator's opinion deems the participant an unsuitable candidate to participate in the study.
See the full eligibility criteria
Who can join
  • Age ≥ 18 years of age.
  • Able to speak, read and comprehend the English language
  • Self-identify as non-Hispanic Black or White.
  • Are \< 24 months of histologically confirmed invasive, non-metastatic, lung cancer diagnosis.
  • Have received surgical treatment (primarily stage I, II and III) and have completed all cancer treatments (surgery, chemotherapy, radiation).
  • Willing to provide biospecimen samples for the study (blood) which will be collected in the comfort of the patient's home by a mobile phlebotomy group.
  • Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related...
What rules you out
  • Participant has in situ (stage 0) or metastatic (stage IV) disease at study entry.
  • Has contraindications for respiratory muscle training (e.g., recent pulmonary embolism, aortic aneurysm, current pneumothorax).
  • Is actively engaging in a structured exercise program and/or meeting exercise guidelines.
  • Unwilling or unable to follow protocol requirements.
  • Any condition which in the investigator's opinion deems the participant an unsuitable candidate to participate in the study.

The study team makes the final eligibility decision.

Where it's taking place

  • Buffalo, New York, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Buffalo, New York, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.